CClinicalTrials.gg
CompletedNCT03572127HAMUpdated Apr 27, 2025

Mycoprotein, Resistance Training, and Hypertrophy

An interventional study of Diet in Hypertrophy, sponsored by University of Exeter. Completed at 1 site in United Kingdom. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-27.

Sponsored by University of Exeter · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Protein is vital for the preservation of health and optimal adaptation to training. However, animal proteins come with economic and environmental issues. The study will investigate the effect of non-animal vs animal based habitual protein consumption on muscle protein metabolism and changes in muscle mass and function over a longer period of time.

Read the detailed description

Protein is vital for the preservation of health and optimal adaptation to training. However, animal proteins come with a number of economic and environmental issues. Accordingly, the investigators need to develop an evidence base for more sustainable dietary proteins to support human nutrition. Mycoprotein is a non-animal protein produced by the continuous fermentation of the fungus Fusarium Venenatum. Previously, in a mechanistic study, it was determined that a single bolus of mycoprotein effectively supports muscle building in both rested and exercised skeletal muscle, to a similar extent as what would be expected of animal proteins. This suggests that similar adaptation of muscle tissue during training could be achieved when protein is obtained from non-animal derived protein sources.

The study will investigate the effect of high non-animal vs animal based habitual protein consumption on muscle protein metabolism and changes in muscle mass and function over a longer period of time. Initially, the study will employ a stable isotope tracer to quantify muscle protein synthesis over a period of three days in healthy male and female volunteers. During this time participants will consume a controlled vegan diet or an animal based diet, with daily unilateral resistance exercise. The second phase of the study will employ a 10 week diet and resistance training intervention, with the majority of a participant's protein either coming from animal or non-animal sources. This will determine the ability of a largely non-animal derived diet to support augmentations in muscle size and strength.

Briefly, participants will undergo 6 muscle biopsies over the course of an 11 week period. Initial biopsies will quantify muscle protein synthesis. Subsequent biopsies will characterise the adaptive response to the effects of nutrition and exercise. MRI scans will be employed to determine changes in muscle volume, and DXA scans will measure changes in body composition.

02

Conditions studied

  • Hypertrophy

Browse trials for

Keywords

  • Protein
  • Resistance Exercise
  • Skeletal Muscle
  • Mycoprotein
  • Sustainability
03

In context

Hypertrophy

656 studies on the registry are indexed under Hypertrophy; 87 are open to participants now.

This study's enrollment of 42 is below the median of 50 across 460 interventional studies indexed under Hypertrophy.

Browse Hypertrophy studies →

Lead sponsor

University of Exeter is the lead sponsor of 138 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males and females 18 - 40 years of age.
  • Body mass index between 18 and 30.
  • Recreationally active.
  • Resistance training experienced (have previous performed resistance exercise, and are familiar with the basic movements).

Exclusion criteria

Exclusion Criteria:

  • Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) (as this may affect normal protein metabolism).
  • Any diagnosed cardiovascular disease or hypertension (to avoid any complications associated with heavy exercise).
  • Elevated blood pressure at the time of screening. (An average systolic blood pressure reading of ≥140mmHg over two or more measurements and an average diastolic blood pressure of ≥90mmHg over two or more measurements.)
  • Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism).
  • A personal or family history of epilepsy, seizures or schizophrenia.
  • Allergic to mycoprotein / Quorn, penicillin, or milk.
  • Pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
42 participants (actual)

Study arms

  • Experimental
    Non-animal derived diet

    High protein diet derived from non-animal sources.

    Other: Diet

  • Active comparator
    Animal derived diet

    High protein diet derived from animal sources.

    Other: Diet

Interventions

  • OtherDiet

    High protein diet derived from either animal or non-animal sources.

06

What researchers measure

Primary outcomes

  1. Muscle Protein Synthesis

    Muscle protein synthesis measured via deuterium oxide

    Time frame: 3 days

Secondary outcomes

  1. Muscle fiber CSA

    Changes in muscle fiber CSA

    Time frame: 10 weeks

  2. Muscle Strength

    Changes in muscle strength

    Time frame: 10 weeks

  3. Muscle CSA

    Changes in muscle CSA as measured by MRI

    Time frame: 10 weeks

07

Study locations

1 site
  • University of Exeter, Sports & Health Sciences, College of Life & Environmental Sciences
    Exeter, Devon EX1 2LU, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03572127
Lead sponsor
University of Exeter
Collaborators
Quorn
Responsible party
Sponsor
First posted
Jun 28, 2018
Start date
May 16, 2018
Primary completion
Mar 1, 2020
Completion
May 1, 2022
Last update
Apr 27, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion